CD8A and COVID-19: These data show that the decrease in functional Kv1.3 channels and Ca2+ signaling brought about by dexamethasone in CD8+ T cells from healthy volunteers and severely ill COVID-19 patients contributes to their attenuated effector functions, thereby establishing a new mechanism for the beneficial effects of dexamethasone in severe COVID-19.